Metabolism of ibuprofen in zebrafish larvae

1. The application of zebrafish (Danio rerio) larvae to drug discovery assays and toxicity testing, and the occurrence of pharmaceuticals in the environment, has resulted in a need to understand the extent of the metabolic capabilities in the early life stages of this species. 2. The aims of this study were to determine if zebrafish larvae absorbed, metabolized and excreted the model pharmaceutical, ibuprofen. Zebrafish larvae (72 h post fertilization) were exposed to ibuprofen (100 mu g/L), C-14-ibuprofen (100 mu g/L) or a solvent control (ethanol) for <= 24 h. Water samples and larval extracts were assessed for metabolites of ibuprofen using liquid chromatography mass spectrometry (LC-MS-MS). Fractions from the separation of the samples treated with C-14-ibuprofen were collected after chromatography and analysed for C-14 content by scintillation counting. 3. Assessment of larval extracts and water samples by LC-MS-MS at 24 h resulted in the identification of hydroxyibuprofen in both water samples and larval extracts (8.2 and 0.08% of the total detected C-14, respectively). A second putative hydroxy-ibuprofen moiety was also observed in water samples at trace levels, and a third minor unknown metabolite was detected in larval extracts only by scintillation counting (0.02% of the total C-14 detected). 4. This study provides evidence that zebrafish larvae can metabolize and excrete ibuprofen in a manner known to be cytochrome P450-dependent in mammals, and the similarity to the mammalian pathway supports the use of this system as a surrogate in toxicity and efficacy screening.